融合DWI与薄层T2加权成像定位胆脂瘤
本研究回顾性纳入24例术前接受MRI颞骨成像并手术证实的胆脂瘤患者,由盲法神经放射科医生在DWI及融合DWI-T2图像上按11个颞骨解剖分区定位病灶,以手术结果为金标准。融合DWI-T2的敏感度、特异度和准确率分别为57.1%、94.8%和81.8%,均高于未融合DWI的52.1%、88.9%和75.8%。
要点
- 融合DWI-T2图像在颞骨胆脂瘤解剖定位上优于未融合DWI图像。
- 该方法仅需MR序列,无需额外CT采集,可能替代MR-CT融合。
- 证据等级为3级,需未来进一步研究验证。
核心结论
- 融合DWI-T2图像在颞骨胆脂瘤解剖定位方面优于未融合DWI图像,是术前评估的潜在替代方法。
研究设计与样本
- 回顾性研究,纳入2011年9月至2020年3月连续24例术前接受MRI颞骨成像(含DWI和薄层T2加权成像)并手术证实的原发性或复发性胆脂瘤患者。
主要发现
- 未融合DWI图像的敏感度、特异度和准确率分别为52.1%、88.9%和75.8%。
- 融合DWI-T2图像的敏感度、特异度和准确率分别为57.1%、94.8%和81.8%。
临床怎么用
- 对于术前评估颞骨胆脂瘤,可采用融合DWI-T2图像进行解剖定位,避免额外CT采集。
局限性
- 证据等级为3级,样本量24例,为回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fusion of diffusion-weighted imaging (DWI) to computed tomography (CT) has been touted as a possible technique to improve cholesteatomas localization. This study set out to assess the ability of DWI images fused with thin-slice heavily T2-weighted images to similarly localize surgically-confirmed cholesteatomas. MATERIALS AND METHODS: A retrospective review was completed of consecutive patients that underwent MR temporal bone imaging (9/2011-3/2020) with both DWI and thin-slice T2-weighted imaging. Included patients underwent surgical resection of primary or recidivistic cholesteatoma after preoperative MR imaging. A neuroradiologist, who was blinded to operative and clinical notes, localized each lesion on both DWI and fused DWI-T2 images in 11 anatomic subdivisions of the temporal bone. Surgical confirmation of cholesteatoma location was used as the gold standard for comparison. RESULTS: Of 24 included examinations, the average age at time of MR was 48.2 ± 24.7 years; 12/24 (50.0%) were female. Five of 24 had primary cholesteatoma, while the remainder had recidivistic disease. Sensitivity, specificity, and accuracy of unfused DWI images were 52.1%, 88.9%, and 75.8%, respectively. Sensitivity, specificity, and accuracy of fused DWI-T2 images were 57.1%, 94.8%, and 81.8%, respectively. CONCLUSION: Fused DWI-T2 images outperformed unfused DWI images in the anatomic localization of temporal bone cholesteatomas. This method represents a potential alternative to MR-CT fusion for pre-operative cholesteatoma evaluation, and warrants future investigations. Opposed to MR-CT fusion, this method only necessitates MR sequences and removes the need for additional CT acquisition. LEVEL OF EVIDENCE: 3 Laryngoscope, 131:E1662-E1667, 2021.
引用
- Benson JC, Carlson ML, Yin L, et al. Cholesteatoma Localization Using Fused Diffusion-Weighted Images and Thin-Slice T2 Weighted Images. Laryngoscope. 2020. PMID: 33140869. doi:10.1002/lary.29222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。